Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success

被引:36
作者
Kontoyiannis, D. P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
prophylaxis; antifungal; SCT; genetic risk; aspergillosis; INVASIVE FUNGAL-INFECTIONS; LIPOSOMAL AMPHOTERICIN-B; POSACONAZOLE PROPHYLAXIS; HIGH-RISK; HEMATOLOGIC MALIGNANCIES; PULMONARY ASPERGILLOSIS; DISEASES SOCIETY; MOLD INFECTIONS; FLUCONAZOLE; POLYMORPHISMS;
D O I
10.1038/bmt.2010.256
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Antifungal prophylaxis in hematopoietic stem cell transplant recipients is a rapidly evolving field. For this prophylaxis to be beneficial and cost-effective, the risk of a life-threatening invasive fungal infection (IFI) should outweigh the risks of toxic effects and drug interactions introduced by the antifungal agent used. Not all hematopoietic stem cell transplant recipients have the same risk of IFIs. New prophylactic strategies using risk stratification and new broad-spectrum antifungals have the potential for reducing IFI-associated mortality in these patients. Further refinement of risk stratification and risk/benefit analysis (including pharmacoeconomic analysis) is needed. Stratification of IFI risk could be further sharpened based on emerging genetic and metabolic risk factors. However, 10 years after deciphering the human genome, it is unclear whether the genomic revolution would pay off for identifying the SCT recipients at highest risk for IFIs. Empiricism and reliance on institution-specific epidemiologic data are still expected to be a major part of the 'art and science' of risk stratification for fungal infections in SCT. Bone Marrow Transplantation (2011) 46, 165-173; doi: 10.1038/bmt.2010.256; published online 1 November 2010
引用
收藏
页码:165 / 173
页数:9
相关论文
共 67 条
[1]   Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis [J].
Ananda-Rajah, M. R. ;
Grigg, A. ;
Slavin, M. A. .
MYCOPATHOLOGIA, 2008, 166 (02) :83-86
[2]   Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications [J].
Andes, David ;
Pascual, Andres ;
Marchetti, Oscar .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :24-34
[3]   Prospective Monitoring for Invasive Aspergillosis Using Galactomannan and Polymerase Chain Reaction in High Risk Pediatric Patients [J].
Armenian, Saro H. ;
Nash, Kevin A. ;
Kapoor, Neena ;
Franklin, Janet L. ;
Gaynon, Paul S. ;
Ross, Lawrence A. ;
Hoffman, Jill A. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (12) :920-926
[4]   Keratinocyte growth factor [J].
Athar, Uzma ;
Gentile, Teresa C. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (06) :779-787
[5]   Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation [J].
Bochud, Pierre-Yves ;
Chien, Jason W. ;
Marr, Kieren A. ;
Leisenring, Wendy M. ;
Upton, Arlo ;
Janer, Marta ;
Rodrigues, Stephanie D. ;
Li, Sarah ;
Hansen, John A. ;
Zhao, Lue Ping ;
Aderem, Alan ;
Boeckh, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1766-1777
[6]   Invasive Fungal Infection in Haematopoietic Stem Cell Transplant Recipients: Epidemiology from the Transplant Physician's Viewpoint [J].
Bow, E. J. .
MYCOPATHOLOGIA, 2009, 168 (06) :283-297
[7]  
Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986
[8]   Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients [J].
Chou, Lillian S. ;
Lewis, Russell E. ;
Ippoliti, Cindy ;
Champlin, Richard E. ;
Kontoyiannis, Dimitrios P. .
PHARMACOTHERAPY, 2007, 27 (12) :1644-1650
[9]   Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia [J].
Collins, Curtis D. ;
Ellis, Jeffrey J. ;
Kaul, Daniel R. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (23) :2237-2243
[10]   Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis [J].
Cordonnier, C. ;
Botterel, F. ;
Ben Amor, R. ;
Pautas, C. ;
Maury, S. ;
Kuentz, M. ;
Hicheri, Y. ;
Bastuji-Garin, S. ;
Bretagne, S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (01) :81-86